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In a pilot-scale, open-label study to determine the ability of well-characterized probiotic Lactobacillus salivarius UCC118 cells to adhere to
human epithelial cells in situ , the bacterial strain was administered to ulcerative colitis patients at approximately 109 CFU/day for 12 days.
Microbiological analysis of biopsy specimens demonstrated that the ingested bacteria effectively adhered to both inflamed and non-inflamed
mucosa of the large bowel in significant numbers. In previous reports, we have described the ability of the lactobacilli to adhere to enterocytic
epithelial cells in vitro . In this study, we found that the bacteria adhered at higher levels to differentiated rather than undifferentiated
epithelial monolayers; and that stationary phase lactobacilli were found to adhere to eukaryotic HT-29 and Caco-2 epithelial cells at greater
levels than log phase bacterial cells. Pretreatment of the Lactobacillus cells with proteolytic enzymes abolished attachment, indicating the
potential involvement of surface/exposed protein(s) as bacterial adhesin(s). SDS-PAGE (denaturing) techniques determined that the
proteolytic treatment resulted in degradation of a cell wall-associated protein of approximately 84 kDa. The proteinaceous factor was
purified by both anion-exchange chromatography and by gel extraction after SDS-PAGE electrophoresis, and under in vitro assay conditions
proved capable of adherence and significant inhibition of bacterial attachment to enterocytic epithelial cells. Key words: probiotic,
Lactobacillus , adhesin, cell-borne, proteinaceous.
INTRODUCTION
In a number of intestinal disease states altered microflora,
impaired gut barrier and/or intestinal inflammation offer a
rationale for the effective therapeutic use of probiotic
microorganisms (1). Such ‘probiotics’, defined as living
microorganisms, which upon ingestion in certain numbers,
exert health affects beyond inherent basic nutrition (2), have
been assessed in human disorders such as small bowel
bacterial overgrowth (3), colorectal cancer (4), diarrhoea
in children (5), traveller’s diarrhoea (6) and antibiotic/
Clostridium difficile -associated diarrhoea (7, 8).
Most commonly, the effects of probiotics require the
consumption of large numbers of cells which then transit, or
persist within, the distinct physiological and chemical
environments of the gut. Influencing factors vary from
acid conditions in the stomach to an alkaline pH in the
small bowel, presence of bile juices, pancreatic secretions
and an active mucosal immune system (1). Proposed
mechanisms through which the ingested probiotic microbes
may subsequently benefit their host include the production
of antimicrobial factors, competition for nutrients, degra-
dation of toxins or eukaryotic toxin receptors and immu-
nomodulation (1). However, of the main criteria for
selecting probiotic strains, adherence to intestinal epithelia
is thought to be paramount (9, 10). Indeed, adhesion to
epithelial cells and/or mucus appears to mediate coloniza-
tion of the gastrointestinal tract by lactobacilli and may be
a prerequisite for competitive exclusion of enteropathogenic
bacteria (11, 12) and immunomodulation of the host
(13/16).
To understand the interactions between bacterial
cells and the surrounding environment and, thereby, the
probiotic traits described above, investigators have begun to
clarify the taxonomy, physiology and genetic properties of
probiotic bacteria (17, 18). These studies have implicated a
number of factors in the attachment of probiotic bacterial
cells to epithelial cells. Such factors include: passive
entrapment of the bacterial cells by fimbrial cell matrix
material (19), bacterial cell surface-associated lipoteichoic
acid (20), proteinaceous extracellular adhesins (21) and
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bacterial cell surface-associated proteinaceous factors
(22, 23).
In addition, studies in patients with Crohn’s disease (24)
and ulcerative colitis (25, 26) have begun to expand the
scientific rationale upon which the concept of bacteriother-
apy of inflammatory bowel disease is based (1, 27). Of
particular relevance to this study, Gionchetti et al. (26)
reported a study of 40 patients with chronic pouchitis, a
long-term complication that can occur following ileal
pouch-anal anastomosis for ulcerative colitis. The results
were convincing / as consumption of the combinational
probiotic product resulted in 85% of the test cohort
maintaining remission throughout the 9-month study
period compared with none of the patients in the control
limb / and promote the prophylactic use of probiotic
mixtures against relapse of the disorder.
In the present study, a dairy-based probiotic product
(24, 28/30) was administered to ulcerative colitis patients.
Subsequent collection of faecal and biopsy specimens
facilitated evaluation using conventional microbiological
techniques of probiotic adhesion to both inflamed and non-
implicated tissue. Laboratory-based biochemical and micro-
scopy experiments characterized the physiological and
biochemical mechanisms mediating the observed adherence
of the strain.
EXPERIMENTAL PROCEDURES
In vivo assessment of L. salivarius UCC118 adherence:
feeding trial in ulcerative colitis patients
Twelve ulcerative colitis patients aged from 20 to 65 years
were recruited to assess the adherence abilities of a
spontaneous rifampicin-resistant derivative of Lactobacillus
salivarius UCC118 (L. salivarius UCC118Rif) within the
human gastrointestinal tract. These individuals were re-
cruited using the following exclusion criteria: no recent
history of antibiotic therapy, no current drug therapy, no
chronic viral illness, no known allergies and no participa-
tion in other clinical trials. In addition, candidates for the
trial were excluded if they were pregnant or suffering from
IgA deficiency. Informed consent was obtained from all
volunteers, and the ethical committee local to Kuopio,
Finland approved the study. The trial subjects consumed a
fermented milk product (100 g) containing viable
L. salivarius UCC118Rif (109 CFU/day) each day for
12 days, and were followed up for a further period of
14 days. All candidates were asked to refrain from
consumption of other known probiotic products for the
duration of the study.
Production of the fermented milk product (to good
manufacturing practice standards) involved inoculating
pasteurized cows’ milk with a spontaneous rifampicin-
resistant derivative of L. salivarius UCC118 (L. salivarius
UCC118Rif) and a commercial strain of Streptococcus
thermophilus. Before inoculation into milk, the Lacto-
bacillus strain was grown in liquid de Mann, Rogosa and
Sharpe (MRS) medium (Oxoid, UK) overnight at 378C,
centrifuged and washed twice in sterile PBS. The inoculated
milk was incubated at 378C until Lactobacillus numbers
reached 108 CFU/g. The product was distributed to Finnish
patients with Lactobacillus UCC118 levels of 107 CFU/g.
Biopsies and excreted faecal specimens were obtained on
days 0, 7, 12, 19 and 26. Microbial analyses were performed
on all biopsy specimens within 6 h of collection. Faecal
specimens were stored at /208C for 24/48 h before
analysis. Each sample was weighed and resuspended in 10
ml of sterile phosphate-buffered saline (PBS). The biopsy
and faecal samples were serially diluted 10-fold in sterile
PBS and spread-plated in appropriate dilutions on MRS
agar (de Mann Rogosa & Sharpe; Oxoid, Hampshire, UK)
supplemented with rifampicin (50 mg/ml). Plates were
incubated anaerobically in GasPakTM jars (BBL) with CO2
generating kits (Anaerocult ATM; Merck) for 2/5 days at
378C. Microbial numbers were calculated as colony forming
units per gram (CFU/g) of biopsy material. No colonies
were observed on the antibiotic-containing medium when
intestinal tissue was assessed prior to probiotic consump-
tion. In addition, selective media were employed for the
culture of total lactic acid bacteria, enterococci, coliforms
and total anaerobic bacteria, respectively, as follows: MRS
agar, Slanetz and Bartley agar, Violet Red Bile agar (VRBA)
and plate count agar respectively (all Oxoid, UK or Difco,
USA). Microbial numbers were calculated as CFU/g of wet
weight faeces.
Following completion of each of the feeding studies, the
numbers of bacteria recovered from faeces and biopsies
were averaged and the standard deviations calculated. All
values were analysed by ANOVA. Where appropriate,
differences were studied using Fisher’s LSD test. All
analyses were performed at the p/ 0.05 level.
Assessment of the effects of eukaryotic and prokaryotic
growth phase on the adherence of L. salivarius UCC118 to
epithelial cells in vitro
HT-29 enterocytic cell lines were cultured as monolayers in
DMEM (Dulbecco’s modified Eagle’s medium; Gibco, UK)
supplemented with 10% (v/v) fetal calf serum (Gibco). Cells
were grown in 75 cm2 tissue culture flasks (Costar, USA) at
378C in a humidified atmosphere containing 5% CO2. At
95% confluence, the monolayers were passaged by incubat-
ing with a 0.25% trypsin solution (Gibco) for 10 min at
378C. The adhesion of the strains was examined using a
modified version of a previously described method (31).
Briefly, monolayers of HT-29 cells were prepared on
sterile 22 mm2 glass coverslips, which were placed in tissue
culture dishes. Cells were seeded at a concentration of
4/104 cells/cm2 and fed fresh medium every 2 days for a
maximum of 10 days. The HT-29 monolayers were washed
twice with PBS. Antibiotic-free DMEM (2 ml) and 2 ml of
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bacterial suspension (containing approx. 109 CFU/ml log
phase, stationary phase or bacterial cells inactivated by
incubation at 808C for 10 min) were added to each dish and
cells were incubated for 120 min at 378C in a humidified
atmosphere containing 5% CO2. After incubation the
monolayers were washed five times with sterile PBS, fixed
with methanol for 3 min, Gram stained and examined
microscopically under oil immersion. For each glass cover-
slip monolayer, the number of adherent bacteria per 20
epithelial cells was counted in 10 microscopic fields. The
mean and standard error of adherent bacteria per 20
epithelial cells was calculated. Each adhesion assay was
performed in triplicate. In a second confirmatory method,
following washing with PBS, adherent bacterial cells were
removed by immersing the monolayers in sterile H2O and
vortex mixing. Bacteria were then enumerated by serial
dilution and incubation on MRS agar. Each adhesion assay
was carried out in triplicate.
When examining adhesion of strain UCC118 to differ-
entiated HT-29 cells in culture, the monolayers were grown
up for 10/14 days on the glass coverslips before the
adhesion assay was performed, as described above. When
assessing bacterial adherence to undifferentiated HT-29
cells, the monolayers were grown for 3/4 days before the
assay.
Biochemical treatments of bacterial cells and spent culture
supernatants
Lactobacillus UCC118 was propagated in MRS broth
(Oxoid) at 378C for 18 h before adherence assays were
performed. Bacterial cells and spent culture supernatant
were separated by centrifugation at 3000 g for 10 min. The
bacterial cells were washed twice in quarter-strength Ring-
er’s solution (Oxoid) and resuspended in an equal volume of
MRS broth before the adhesion assay was performed, as
described above. In another experiment, the bacterial cells
were treated with trypsin (2.5 mg/ml; Sigma T-4665: EC
3.4.21.4) for 60 min at 378C, centrifuged, washed twice in
quarter-strength Ringer’s solution and resuspended in MRS
before the adhesion assay. In a third experiment, the spent
culture supernatant alone was also treated with trypsin
under identical conditions. Trypsin was then inactivated by
the addition of 2 ml of heat-inactivated (608C, 30 min) FCS
before the supernatant was used to resuspend the previously
centrifuged bacterial cells and the adherence assay was
completed. To determine the involvement of carbohydrates
in L. salivarius UCC118 adherence, bacterial cells were pre-
incubated with metaperiodate (50 mM; Sigma S-1878) for
30 min at 378C, centrifuged, washed twice and resuspended
as before. Alternatively, the HT-29 monolayers were washed
five times with 2 ml of the chelating agent ethylene diamine
tetra-acetic acid (EDTA, 20 mM; Sigma E-1644) in PBS
following addition of the bacterial cells.
Polyacrylamide gel electrophoresis of cell wall-associated
proteins
Strain UCC118 was propagated in MRS broth (50 ml) at
378C for 18 h. Both untreated and trypsin-treated bacterial
cells were washed three times in quarter-strength Ringer’s
solution before being resuspended in 2 ml TEL solution
(100 mM Tris-HCl, pH 8.0, 5 mM EDTA and 1% lysozyme)
and incubated for 3 h at 378C. Supernatant was collected
following centrifugation at 3000 g for 10 min. The obtained
cell extracts were electrophoresed on denaturing polyacry-
lamide gels (10% SDS) as described previously (32).
Selected cell extracts post-FPLC (fast protein liquid chro-
matography) isolation were also electrophoresed on dena-
turing polyacrylamide gels (10% SDS) as described
previously (32). All images were captured using a digital
camera (Finepix model 2600, Fuji, Japan).
FPLC isolation and functional assessment of L. salivarius
UCC118 cell-borne factors
Cell extracts (as above) were filter-sterilized and concen-
trated (/20) by filtration through ‘Centricon’ spin columns
with a 50-kDa cut-off (Amicon, USA). Concentrates were
dialysed against 50 mM Tris-HCl, 0.05% (w/v) NaN3,
0.15 M NaCl (pH 7.0) for 12 h and proteins were separated
on a ‘Hiload’ Superdex 75 preparation grade gel filtration
column (26/60 cm; Pharmacia Biotech AB, S-75182
Uppsala, Sweden) equilibrated with the same buffer. Bound
proteins were eluted with a gradient between 0 and 500 mM
NaCl in the same buffer. Eight-ml fractions were collected
using the FPLC GradifracTM system (Pharmacia). Each
fraction was assessed for protein content by measuring the
optical density (OD) at 280 nm using a Beckman DU640
spectrophotometer and cuvettes of 1 cm path-length.
Fractions found to contain proteinaceous material were
assessed for the ability to influence the adherence of
L. salivarius UCC118 to HT-29 cells when added to the
monolayer prior to the adhesion assay as described above.
Assessment, exploiting fluorescent labelling, of in vitro
adherence of UCC118-borne cell wall factors to epithelial
cells
HT29 cells were cultured in 24-well plates at 378C in a
humidified atmosphere of 5% CO2, in DMEM, supplemen-
ted with 10% iron-supplemented donor calf serum, 50 mg/ml
gentamicin, 300 mg/ml L-glutamine and 10 mM HEPES,
pH 7.4. The ‘peptide’ (84 kDa) was labelled with an Alexa
488 fluorescent dye as per the manufacturer’s protocol
(Molecular Probes, Oregon, USA). The purified fluorescent
conjugate (free of any unbound fluorescent dye) was
resuspended in a PBS solution and incubated with the
HT29 cells for 2 h at 378C in a humidified atmosphere of
5% CO2.
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Images of the HT29 cells were obtained 2 h after exposure
(at 100/magnification) using an inverted fluorescence
microscope (Nikon TE2000-S) equipped with standard
FITC filters. The peptide/Alexa 488 fluorescent conjugate
PBS solution was removed from the wells of the plate and
washed five times with 2 ml of PBS, with images of the
HT29 cells being taken at each step.
RESULTS
Enumeration of ingested L. salivarius UCC118 following
transit through the gut of ulcerative colitis patients and
evaluation of adhesion to intestinal tissue
Each of the 12 recruited patients completed the study,
without obvious adverse reactions. Prior to initiation of the
probiotic feeding regime (day 0), there were no rifampicin-
resistant bacteria detected in the faecal or biopsy specimens
obtained from the patients. However, immediately following
cessation of feeding (day 12), all of the individuals
administered the probiotic product were found to have
excreted lactobacilli resistant to the antibiotic at levels of
4.0/103/6.3/105 CFU/biopsy or g wet weight faeces,
respectively (Table I). These bacteria were confirmed to be
L. salivarius UCC118 Rif on the basis of the ability to
inhibit the growth of the B. coagulans 1761 indicator strain
on solid media, previously described as being due to the
excretion of a potent bacteriocin-like antimicrobial agent
(33). This also confirmed general compliance with the
feeding regimen. Furthermore, it was evident that Lacto-
bacillus UCC118 adhered to different anatomical regions of
the large bowel and, significantly, to both inflamed and
non-inflamed mucosa of the gastrointestinal tract. Overall,
after cessation of feeding the ingested L. salivarius UCC118
strain was found to represent approximately 1/2% of total
recoverable lactobacilli from both biopsy and faecal sam-
ples, representing 103/105 CFU. Further microbiological
analysis of faecal and biopsy samples during the 14-day
follow-up period demonstrated that the UCC118 strain
continued to be excreted (2/102 CFU/g wet weight faeces
on day 19) and remained associated with intestinal mucosa
(102 CFU on day 19) (Table I), albeit for a relatively short
period. There were no significant differences observed in the
numbers of lactobacilli, bifidobacteria, enterococci, bacter-
oides or coliforms excreted or associated with biopsy tissue
as a result of the probiotic consumption (data not shown).
Characterization of factors mediating attachment of L.
salivarius UCC118 to epithelial cells
As expected, Lactobacillus UCC118 was found to adhere at
significantly higher levels to differentiated versus undiffer-
entiated HT-29 monolayers (Fig. 1a). In addition, the
adhesive properties of Lactobacillus UCC118 were signifi-
cantly greater for stationary phase cells compared with
those in logarimetric phase (Fig. 1b). Heat-inactivated
Table I
Levels of L. salivarius UCC118 recovered from biopsy tissue and
excreted faecal specimens collected from ulcerative colitis patients
(n/12) throughout the feeding study*
Days on which
specimens were
collected$
Average levels of
L. salivarius UCC118
detected from biopsy
tissue (CFU)
Average levels of
L. salivarius UCC118
detected from excreted
faeces (CFU/g wet
weight)
0 0 0
7 2.0/102 2.5/105
12 4.0/103 6.3/105
19 1.0/102 2.0/102
26 ND ND
ND, not detected.
*The trial subjects consumed a fermented milk product (100 g)
containing viable L. salivarius UCC118Rif (109 CFU/day) each day
for 12 days, and were followed up for a further period of 14 days.
$Microbial analyses were performed on all biopsy specimens within
6 h of collection, and on all faecal samples within 48 h following
frozen storage. Specimens were weighed and resuspended in sterile
phosphate-buffered saline (PBS) before serial dilution and incuba-
tion on MRS agar supplemented with rifampicin (50 mg/ml).
 
Fig. 1. Adherence of probiotic L. salivarius UCC118 cells to HT-29
epithelial cell monolayer. (a) It is evident that the bacterial cells
adhere at a greater level when introduced onto differentiated
epithelial cells. (b) The L. salivarius UCC118 cells adhere at a
greater level when introduced into the assay during the stationary
phase of bacterial growth.
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UCC118 cells were also capable of attaching to the
eukaryotic cells, indicating that adhesion of the probiotic
strain is not intrinsically associated with ongoing biological
activity (data not shown).
Washing Lactobacillus UCC118 cells with sterile quarter-
strength Ringer’s solution had no obvious effect on the
ability of the lactobacilli to adhere to the HT-29 monolayers
(Fig. 2). However, pre-incubation of the Lactobacillus cells
with trypsin resulted in a significant reduction in bacterial
adhesion while treatment of the culture supernatant (as
described) did not (Fig. 2), suggesting that a cell-associated
proteinaceous factor(s) mediates the attachment of the
probiotic strain to epithelial cells. Metaperiodate treatment
(to determine the involvement of carbohydrate moieties in
Lactobacillus UCC118 adherence) and EDTA treatment (to
determine calcium involvement) did not significantly impair
adhesion of the bacterial cells (Fig. 2).
Determination of the nature of Lactobacillus UCC118 cell
wall-associated factors
The cell wall-associated proteins of both control and
trypsin-treated Lactobacillus UCC118 cells were isolated
using a treatment designed to prevent gross contamination
of the preparation by intracellular material. The resulting
preparations, containing a putative cell wall-borne adhesion
factor(s), were then separated using SDS-PAGE. The
resulting profiles (Fig. 3) were found to differ by the
absence in the trypsin-treated sample of two specific protein
bands of approximately 100 kDa and 84 kDa, presumably
due to proteolytic degradation (data not shown).
Partial purification and functional characterization of the
Lactobacillus UCC118 cell-borne adhesin
The proteinaceous material associated with the Lactobacil-
lus UCC118 cell wall was isolated by passage through a gel
filtration column. The protein content of each of the
collected fractions was determined and resulted in the
identification of six obvious peaks (Fig. 4a). Each of these
fractions, in addition to a protein-free fraction, was pre-
incubated on HT-29 cells prior to the completion of an
assay evaluating the adherence of Lactobacillus UCC118
cells to the eukaryotic cell line. Of the seven fractions tested,
only one (fraction 18), demonstrated an ability to signifi-
cantly influence the attachment of the introduced lactoba-
cilli to the HT-29 cells (Fig. 4b). The observed reduction in
the levels of recovered Lactobacillus UCC118 cells by
approximately 60% indicated the presence in fraction 18
of a factor capable / possibly through competitive occupa-
tion of available sites of adherence / of impairing the
attachment of Lactobacillus UCC118 cells (Fig. 4b).
The content of fraction 18 was subjected to SDS-PAGE
and a single band of approximately 84 kDa was observed
(Fig. 5a). The 84-kDa band was extracted from the SDS gel
and labelled with a commercially available fluorescent tag (a
control peptide of 100 kDa was similarly extracted and
labelled and incorporated into the study as a control) that
enabled detection of the test peptide (but not the control)
attached to HT-29 cells after incubation and washing,
indicating that the 84-kDa peptide is capable of adherence
to eukaryotic cells (Fig. 5b).
DISCUSSION
The human gastrointestinal environment is a complex,
interactive system involving many microbial species, in-
gested dietary components and, perhaps most importantly,
the host itself. Measurement of ingested probiotic microbes
from faecal material and biopsy tissue is problematic if the
administered bacterial strains do not possess specific
characteristics that facilitate their differentiation from
indigenous, closely related, strains (34, 35). For the pur-
poses of this study, a previously selected rifampicin-resistant
Fig. 2. Adherence of probiotic L. salivarius UCC118 cells to HT-29
epithelial cell monolayer. The adherence of the bacterial cells is
mediated by the presence of a proteinaceous, cell-associated factor.
This trait can be negatively influenced by treatment of the bacterial
cells with trypsin.
Fig. 3. Gel electrophoresis (SDS-PAGE) of L. salivarius UCC118
proteinaceous, cell-associated factors. The two lanes with several
bands are the profiles obtained following two separate extractions.
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derivative of L. salivarius UCC118 (30) was used to
facilitate enumeration of the strain from collected samples,
and as a defined method of distinguishing the administered
strain from indigenous lactobacilli. A confirmatory condi-
tion-specific assay was also employed based on the ability of
the strain to produce a potent bacteriocin-like antimicrobial
agent (33).
As in previous studies completed in healthy volunteers
(36) and mild-moderately active Crohn’s disease patients
(24), the probiotic bacteria were administered to the
ulcerative colitis patients as components of a fermented
milk product. There has been unresolved speculation as to
whether the health benefits associated with probiotic
consumption are dependent on the microorganisms becom-
ing long-term residents in the gut. However, in this study
the introduced lactobacilli were detected at levels compar-
able to those observed in the previously reported studies
(24, 36), and they remained recoverable, at least at low
levels, for a period of 7 days after cessation of consumption.
This suggests that continual ingestion of beneficial microbes
will probably be required for most individuals if probiotics
in their current form are to be exploited for enhancement of
health.
To evaluate whether the ingested L. salivarius UCC118
cells simply transited the lumen of the digestive tract
without any direct engagement with the host or became
adherent to the mucosa, biopsy specimens were collected at
each of the time points. Analysis of the data showed that the
probiotic lactobacilli were capable of attaching to the
mucosa (both inflamed and healthy) at detectable levels,
Fig. 4. (a) Purification of proteinaceous, cell-associated factors from L. salivarius UCC118 by gel filtration chromatography. Analysis of the
protein content of the collected FPLC fractions shows obvious peaks at fractions 8, 12, 18, 20, 32 and 38. (b) Adherence of L. salivarius
UCC118 cells to HT-29 epithelial cell monolayer. It is apparent that the adherence of the bacterial cells is significantly reduced when fraction
18 is added prior to the bacterial cells (p/0.049). FPLC fractions 8, 12, 20, 32, 38 and 48 do not significantly affect adherence of
L. salivarius UCC118 cells. Error bars represent standard deviation.
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indicating that this strain may be suitable for development
as a vehicle for targeted delivery of therapeutic agents
(including proteins, enzymes and cytokines). No significant
changes were observed in any of the selected bacterial
species assayed for using both faecal and biopsy tissue
specimens at each of the time points.
These observations prompted investigation of the adher-
ence trait observed with this strain in vivo. To assess
probiotic adherence, in vitro adhesion assays have been
developed which are thought to reflect the ability of
consumed bacteria to persist within the intestinal tract
(13/15). Blum et al. (10) described an evaluation of
methodologies recognizing that results obtained by different
laboratories using identical probiotic strains but varying
experimental conditions can fluctuate widely. The report
presents a comparative assessment of three well-character-
ized probiotic bacterial strains under rigidly defined
conditions; concluding that differentiated enterocytes
(e.g. HT-29) and intestinal mucus are suitable for prelimin-
ary comparison of probiotic strains. In the present study,
following the guidelines suggested by Blum et al. (10) it was
observed that the Lactobacillus UCC118 cells adhered at a
significantly higher level to differentiated rather than
undifferentiated monolayers, while stationary phase Lacto-
bacillus UCC118 cells exhibited a better capacity for
adherence than log phase cells; possibly due to the
proliferation or alteration of adhesion components/factors
as the cells age. Chemical treatment of the probiotic lactic
acid bacteria indicated that adhesion of the lactobacilli was
mediated by a cell-borne trypsin-sensitive moiety.
Development of an extraction method based on a
combination of Tris-HCl, EDTA and lysozyme facilitated
the isolation of proteinaceous factors from the Lactobacil-
lus UCC118 cell wall, and confirmation of the involvement
of a distinct cell wall component through functional assays
based on competitive occupation of adhesion sites and
fluorescent microscopy.
In summary, this study provided evidence for the transit,
and adherence to intestinal mucosa, of probiotic Lacto-
bacillus UCC118 following ingestion by ulcerative colitis
patients. In itself, this feeding study facilitated optimization
by the Irish and Finnish research groups of standard
operating procedures for the manufacture and distribution
of probiotic products; experience that would prove invalu-
able at the initiation of large-scale clinical studies in
Spanish, French, Irish and Finnish inflammatory bowel
disease patients to be completed as part of the PROEU-
HEALTH cluster funded by the European Commission
(PROGID: QLK1-2000-00563). In addition, determination
of the factors mediating the observed adherence abilities of
the strain may, in time, provide the mechanisms through
which molecular therapeutics are delivered in situ .
Fig. 5. (a) Gel electrophoresis (SDS-PAGE) of a Lactobacillus UCC118 proteinaceous, cell-associated factor present in FPLC fraction 18.
This protein band corresponds with the protein band having an approximate molecular weight of 84 kDa seen in Fig. 3. (b) Bright-field and
fluorescent microscopy assessing the adherence of the 84-kDa peptide to HT-29 cells. a) Bright-field view (100/) of eukaryotic cells after the
introduction of fluorescently labelled control peptide (100 kDa); b) identical field viewed (100/) using GFP filter; c) bright-field view
(100/) of eukaryotic cells after the introduction of the fluorescently labelled 84-kDa peptide; d) identical field viewed (100/) using GFP
filter.
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